Immunoresponsiveness in Chronic Hepatitis C Patients: Correlation Between Tissue and Serum Findings

References

• Kuo G., Choo Q.-L., Alter H. J., Gitnick G. L., Redeker A. G., Purcell R. H., Miyamura T., Dienstag J. L., Alter M. J., Stevens C. E., Tegtmeier G. E., Bonino F., Colombo M., Lee W. S., Kuo C., Berger K., Shuster J. R., Overby L. R., Bradley D. W., Houghton M. An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science 1989; 244: 362
   PubMed Web of Science ®Google Scholar
• Dienstag J. L. Hepatitis non-A, non-B: C at last. Gastroenterology 1990; 99: 1177
   PubMed Web of Science ®Google Scholar
• Rice C. M., Walker C M. Hepatitis C virus-specific T lymphocyte responses. Curr. Opin. Immunol 1995; 7: 532
   PubMed Web of Science ®Google Scholar
• Cerny A., Chisari F. V. Immunological aspects of HCV infection. Intervirology 1994; 37: 119
   PubMed Web of Science ®Google Scholar
• Fiore G., Jirillo E., Schiraldi O., Antonaci S. Hepatitis C virus infection: biological and immunological features. Rec. Progr. Med 1996; 87: 1
   PubMedGoogle Scholar
• Fiore G., Piazzolla G., Angarano I., Galetta V., Caccetta L., Jirillo E., Schiraldi O., Antonaci S. Intrahepatic cytotoxic cell infiltrates in chronic hepatitis B and C: a comparative immunohistochemical study. Med. Sci. Res. 1997; 25: 755
   Google Scholar
• Koziel M. J., Dudley D., Wong J. T., Dienstag J., Houghton M., Ralston R., Walker B. D. Intrahepatic cytotoxic T lymphocytes specific for hepatitis C virus in persons with chronic hepatitis. J. Immunol. 1992; 149: 3339
   PubMed Web of Science ®Google Scholar
• Nelson D. R., Marousis C. G., Davis G. L., Rice G. M., Wong J., Houghton M., Lau J. Y.N. The role of hepatitis C virus-specific cytotoxic T lymphocytes in chronic hepatitis C. J. Immunol. 1997; 158: 1473
   PubMed Web of Science ®Google Scholar
• Garcia-Monzon C., Sanchez-Madrid F., Garcia-Buey L., Garcia-Arreys A., Garcia-Sanchez A., Moreno-Otero R. Vascular adhesion molecule expression in viral chronic hepatitis: evidence of neoangiogenesis in portal tract. Gastroenterology 1995; 108: 231
   PubMed Web of Science ®Google Scholar
• Ballardini G., Groff P., Pontisso P., Giostra F., Francesconi R., Lenzi M., Zauli D., Alberti A., Bianchi F. B. Hepatitis C virus (HCV) genotype, tissue HCV antigens, hepatocellular expression of HLA-A,B,C, and intercellular adhesion-1 molecules. J. Clin. Invest. 1995; 95: 2067
   PubMed Web of Science ®Google Scholar
• Fiore G., Angarano I., Caccetta L., Serrone M., Jirillo E., Schiraldi O., Antonaci S. In-situ immunophenotyping study of hepatic infiltrating cytotoxic cells in chronic active hepatitis C. Eur. J Gastroenterol. Hepatol. 1997; 9: 491
   PubMed Web of Science ®Google Scholar
• Puppo F., Picciotto A., Brenci F., Varagona G., Scudeletti M., Ghio M., Balestra V., Celle G., Indiveri F. Behavior of soluble HLA class I antigens in patients with chronic hepatitis C during interferon therapy: an early predictor of response?. J. Clin. Immunol. 1995; 15: 179
   PubMed Web of Science ®Google Scholar
• Hagihara M., Shimura T., Takebe K., Munkhbat B., Yamamoto K., Hosoi K., Kagawa T., Watanabe N., Matsuzaki S., Tsuji K. The changes of serum soluble HLA-class I and CD8 concentrations during interferon treatment of chronic hepatitis C patients. Int. Hepatol. Commun. 1997; 6: 316
   Google Scholar
• Marui A., Fukuda J., Koyama Y., Nakano I., Urano F., Yamada M., Hayakawa T. Serum levels of soluble intercellular adhesion molecule-1 and soluble vascular cell adhesion molecule-1 in liver disease, and their changes by treatment with interferon. J. Int. Med. Res. 1996; 24: 258
   PubMed Web of Science ®Google Scholar
• Jirillo E., Greco B., Caradonna L., Satalino R., Pugliese V., Cozzolongo R., Cuppone R., Manghisi O. G. Evaluation of cellular immune responses and soluble mediators in patients with chronic hepatitis C virus (cHCV) infection. Immunopharmacol. Immunotoxicol. 1995; 17: 347
   PubMed Web of Science ®Google Scholar
• Yang S. S., Tsai G., Wu C. H., Chen D. S. Circulating soluble intercellular adhesion molecule-1 in type C viral hepatitis. Hepato-Gastroenterol. 1996; 43: 575
   PubMedGoogle Scholar
• Zohrens G., Armbrust J., Pirzer U., Meyer zum Büshenfelde K. H., Ramadori G. Intercellular adhesion molecule-1 concentration in sera of patients with acute and chronic liver disease: relationship to disease activity and cirrhosis. Hepatology 1993; 18: 798
   PubMed Web of Science ®Google Scholar
• Brieva J. A., Villar L. M., Leoro G., Alvarez-Cermeño J. C., Roldan E., Gonzalez-Porqué P. Soluble HLA class I antigen secretion by normal lymphocytes: relationship with cell activation and effect of interferon-gamma. Clin. Exp. Immunol. 1990; 82: 390
   PubMed Web of Science ®Google Scholar
• Stevenson F. K., George A. J.T., Walters M. T., Hamblin T. J. Analysis of soluble HLA-class I antigenic material in patients with immunological disease using monoclonal antibodies. J. Immunol. 1986; 86: 187
   Google Scholar
• Quiroga J. A., Martin J., Pardo M., Carreno V. Serum levels of soluble immune factors and pathogenesis of chronic hepatitis C, and their relation to therapeutic response to interferon-α. Dig. Dis. Sci. 1994; 39: 2485
   PubMed Web of Science ®Google Scholar
• Missale G., Rochford R., Hobbs M., Ferrari C., Fiaccadori F., Chisari F. V. Intrahepatic cytokine messenger RNA expression in chronic hepatitis B virus (HBV) and hepatitis C virus (HCV) infections. Ital. J. Gastroenterol. 1994; 26: 209
   Google Scholar
• International Group, Acute and chronic hepatitis revised. Lancet 1977; 2: 914
   PubMed Web of Science ®Google Scholar
• Knodell R. G., Ishak K. G., Black W. C., Chen T. C., Craig R., Kaplowits N., Kienan T. W. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1981; 1: 431
   PubMed Web of Science ®Google Scholar
• Mosnier J. F., Scoazec J. Y., Marcellin P., Degott C., Benhamou J. P., Feldmann G. Expression of cytokine-dependent immune adhesion molecules by hepatocytes and bile duct cells in chronic hepatitis C. Gastroenterology 1994; 107: 1457
   PubMed Web of Science ®Google Scholar
• Khakoo S. I., Soni P. N., Savage K., Brown D., Dhillon A. P., Poulter L. W., Dusheiko G. M. Lymphocyte and macrophage phenotypes in chronic hepatitis C infection. Am. J. Pathol. 1997; 150: 963
   PubMed Web of Science ®Google Scholar
• Weistål R. Immune-mediated liver damage in chronic hepatitis C. Scand. J. Gastroenterol. 1995; 30: 609
   PubMed Web of Science ®Google Scholar
• Brodsky F. M., Guagliardi L. E. The cell biology of antigen processing and presentation. Annu. Rev. Immunol. 1991; 9: 707
   PubMed Web of Science ®Google Scholar
• Springer T. A. Adhesion receptors of the immune system. Nature 1990; 346: 425
   PubMed Web of Science ®Google Scholar
• Volpes R., Van der Oord J. J., Desmet V. J. Immunohistochemical study of adhesion molecules in liver inflammation. Hepatology 1990; 12: 59
   PubMed Web of Science ®Google Scholar
• Volpes R., Van der Oord J. J., Desmet V. J. Vascular adhesion molecules in acute and chronic liver inflammation. Hepatology 1992; 15: 269
   PubMed Web of Science ®Google Scholar
• Chu C. M., Liaw Y. F. Coexpression of intercellular adhesion molecuie-1 and class I major histocompatibility complex antigens on hepatocyte membrane in chronic viral hepatitis. J. Clin. Pathol. 1993; 46: 1004
   PubMed Web of Science ®Google Scholar
• Piazzolla G., Giannelli G., Antonelli G., Tortorella C., Jirillo E., Schiraldi O., Antonaci S. Effects of interferon-α treatment on neutrophil oxidative metabolism, lymphocyte proliferation and monocyte HLA class I antigen expression in patients with chronic hepatitis C. Immunopharmacol. Immunotoxicol. 1996; 18: 529
   PubMed Web of Science ®Google Scholar
• Kurosaki M., Enomoto N., Marumo F., Sato C. Rapid sequence variation of the hypervariable region of hepatitis C virus during the course of chronic infection. Hepatology 1993; 18: 1293
   PubMed Web of Science ®Google Scholar
• Chisari F. V. Cytotoxic T cells and viral hepatitis. J. Clin. Invest. 1997; 99: 1472
   PubMed Web of Science ®Google Scholar
• Ciccone E., Grossi C. E., Velardi A. Opposing functions of activatory T-cell receptors and inhibitory NK-cell receptors on cytotoxic T cells. Immunol. Today 1996; 17: 450
   PubMedGoogle Scholar
• Puppo F., Scudeletti M., Indiveri F., Ferrone S. Serum HLA class I antigens: markers and modulators of an immune response?. Immunol. Today 1995; 16: 124
   PubMedGoogle Scholar
• Zavazava N., Krönke M. Soluble HLA class I molecules induce apoptosis in alloreactive cytotoxic T lymphocytes. Nature Med. 1996; 2: 1005
   PubMed Web of Science ®Google Scholar
• Abastado J. P., Lone Y. C., Casrouge A., Boulot G., Kourilsky P. Dimerization of soluble Major Histocompatibility Complex-peptide complexes is sufficient for activation of T cell Hybridoma and induction of unresponsiveness. J. Exp. Med. 1995; 182: 439
   PubMed Web of Science ®Google Scholar